Silencing PEX26 as an unconventional mode to kill drug-resistant cancer cells and forestall drug resistance

DOI Web Site 1 Citations

Michael S. Dahabieh

Lady Davis Institute, McGill University, Montréal, Canada
Fan Huang

Lady Davis Institute, McGill University, Montréal, Canada
Christophe Goncalves

Lady Davis Institute, McGill University, Montréal, Canada
Raúl Ernesto Flores González

Lady Davis Institute, McGill University, Montréal, Canada
Sathyen Prabhu

Lady Davis Institute, McGill University, Montréal, Canada
Alicia Bolt

Lady Davis Institute, McGill University, Montréal, Canada
Erminia Di Pietro

Department of Human Genetics and Pediatrics, Research Institute of McGill University Children’s Hospital, Montréal, Canada
Elie Khoury

Lady Davis Institute, McGill University, Montréal, Canada
John Heath

Lady Davis Institute, McGill University, Montréal, Canada
Zi Yi Xu

Lady Davis Institute, McGill University, Montréal, Canada
Joelle Rémy-Sarrazin

Lady Davis Institute, McGill University, Montréal, Canada
Koren K. Mann

Lady Davis Institute, McGill University, Montréal, Canada
Alexandre Orthwein

Lady Davis Institute, McGill University, Montréal, Canada
François-Michel Boisvert

Département d’anatomie et de biologie cellulaire, Université de Sherbrooke, Sherbrooke, Canada
Nancy Braverman

Department of Human Genetics and Pediatrics, Research Institute of McGill University Children’s Hospital, Montréal, Canada
Wilson H. Miller

Lady Davis Institute, McGill University, Montréal, Canada
Sonia V. del Rincón

Lady Davis Institute, McGill University, Montréal, Canada

Search this article

Back to top